MMP inhibitors have thus far underperformed in therapeutic studies, partly owing to the presence of multitudes of MMP enhancers and activators.35 The NF2−/− human schwannoma cell line (HEI-193) overexpress and secrete MMP9 in vitro (Figure 5A and B). Here, MMP9 is linked to schwannoma.